Effect of dark‑colored maple syrup on cell proliferation of human gastrointestinal cancer cell

Yamamoto,Tetsushi; Sato,Kanta; Kubota,Yuika; Mitamura,Kuniko; Taga,Atsushi

doi:10.3892/br.2017.910

Effect of dark‑colored maple syrup on cell proliferation of human gastrointestinal cancer cell

Authors:
- Tetsushi Yamamoto
- Kanta Sato
- Yuika Kubota
- Kuniko Mitamura
- Atsushi Taga
View Affiliations

Affiliations: Pathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Higashi‑Osaka, Osaka 577‑8502, Japan
Published online on: May 16, 2017 https://doi.org/10.3892/br.2017.910
Pages: 6-10
Copyright: © Yamamoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Maple syrup is a natural sweetener that is commonly consumed worldwide. While maple syrup mainly comprises sucrose, it also contains phytochemicals that present various biological effects. Maple syrup is made by boiling down sap, and its color and composition vary in accordance with the sap collection season. Typically, seasonal progression is associated with darker syrup color, and antioxidant activity is proportional to the increasingly dark color. The authors previously reported that maple syrup demonstrated inhibitory effects on colorectal cancer cell growth and invasion, which correlated with darker maple syrup color. In the present study, they examined the effects of two different grades of maple syrup on gastrointestinal cancer cell proliferation, to investigate whether the dark‑color maple syrup was suitable as a phytomedicine for gastrointestinal cancer treatment. Administration of dark‑color maple syrup significantly inhibited gastrointestinal cancer cell growth as compared to non‑treated cancer cells. Moreover, administration of dark‑color maple syrup clearly inhibited protein kinase B (AKT) phosphorylation and did not impact mitogen‑associated protein kinase phosphorylation. These data suggested that dark‑color maple syrup may inhibit cell proliferation through suppression of AKT activation and, thus, may be suitable as a phytomedicine for gastrointestinal cancer treatment.

View Figures

View References

1	Ball DW: The chemical composition of maple syrup. J Chem Educ. 84:1647–U1646. 2007. View Article : Google Scholar
2	Perkins TD and van den Berg AK: Maple syrup-production, composition, chemistry, and sensory characteristics. Adv Food Nutr Res. 56:101–143. 2009. View Article : Google Scholar : PubMed/NCBI
3	Arnason T, Hebda RJ and Johns T: Use of plants for food and medicine by Native Peoples of eastern Canada. Can J Bot. 59:2189–2325. 1981. View Article : Google Scholar
4	Davison RM and Young H: Abscisic-acid content of xylem sap. Planta. 109:95–98. 1973. View Article : Google Scholar : PubMed/NCBI
5	Taga A, Sato A, Suzuki K, Takeda M and Kodama S: Simple determination of a strongly aromatic compound, sotolon, by capillary electrophoresis. J Oleo Sci. 61:45–48. 2012. View Article : Google Scholar : PubMed/NCBI
6	Taga A and Kodama S: Analysis of reducing carbohydrates and fructosyl saccharides in maple syrup and maple sugar by CE. Chromatographia. 75:1009–1016. 2012. View Article : Google Scholar
7	Storz G, Darvill AG and Albersheim P: Characterization of polysaccharides isolated from maple syrup. Phytochemistry. 25:437–441. 1986. View Article : Google Scholar
8	Sun J, Ma H, Seeram NP and Rowley DC: Detection of Inulin, a Prebiotic Polysaccharide, in Maple Syrup. J Agric Food Chem. 64:7142–7147. 2016. View Article : Google Scholar : PubMed/NCBI
9	Apostolidis E, Li LY, Lee C and Seeram NP: In vitro evaluation of phenolic-enriched maple syrup extracts for inhibition of carbohydrate hydrolyzing enzymes relevant to type 2 diabetes management. J Funct Foods. 3:100–106. 2011. View Article : Google Scholar
10	Legault J, Girard-Lalancette K, Grenon C, Dussault C and Pichette A: Antioxidant activity, inhibition of nitric oxide overproduction, and in vitro antiproliferative effect of maple sap and syrup from Acer saccharum. J Med Food. 13:460–468. 2010. View Article : Google Scholar : PubMed/NCBI
11	González-Sarrías A, Li L and Seeram NP: Effects of maple (Acer) plant part extracts on proliferation, apoptosis and cell cycle arrest of human tumorigenic and non-tumorigenic colon cells. Phytother Res. 26:995–1002. 2012. View Article : Google Scholar : PubMed/NCBI
12	Li L and Seeram NP: Maple syrup phytochemicals include lignans, coumarins, a stilbene, and other previously unreported antioxidant phenolic compounds. J Agric Food Chem. 58:11673–11679. 2010. View Article : Google Scholar : PubMed/NCBI
13	Theriault M, Caillet S, Kermasha S and Lacroix M: Antioxidant, antiradical and antimutagenic activities of phenolic compounds present in maple products. Food Chem. 98:490–501. 2006. View Article : Google Scholar
14	Hawco CLA, Wang Y, Taylor M and Weaver DF: A maple syrup extract prevents β-amyloid aggregation. Can J Neurol Sci. 43:198–201. 2016. View Article : Google Scholar : PubMed/NCBI
15	Aaron C, Beaudry G, Parker JA and Therrien M: Maple Syrup Decreases TDP-43 Proteotoxicity in a Caenorhabditis elegans Model of Amyotrophic Lateral Sclerosis (ALS). J Agric Food Chem. 64:3338–3344. 2016. View Article : Google Scholar : PubMed/NCBI
16	Maisuria VB, Hosseinidoust Z and Tufenkji N: Polyphenolic extract from maple syrup potentiates antibiotic susceptibility and reduces biofilm formation of pathogenic bacteria. Appl Environ Microbiol. 81:3782–3792. 2015. View Article : Google Scholar : PubMed/NCBI
17	Ma H, DaSilva NA, Liu W, Nahar PP, Wei Z, Liu Y, Pham PT, Crews R, Vattem DA, Slitt AL, et al: Effects of a Standardized Phenolic-Enriched Maple Syrup Extract on β-Amyloid Aggregation, Neuroinflammation in Microglial and Neuronal Cells, and β-Amyloid Induced Neurotoxicity in Caenorhabditis elegans. Neurochem Res. 41:2836–2847. 2016. View Article : Google Scholar : PubMed/NCBI
18	Nagai N, Ito Y and Taga A: Comparison of the enhancement of plasma glucose levels in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats by oral administration of sucrose or maple syrup. J Oleo Sci. 62:737–743. 2013. View Article : Google Scholar : PubMed/NCBI
19	Yamamoto T, Uemura K, Moriyama K, Mitamura K and Taga A: Inhibitory effect of maple syrup on the cell growth and invasion of human colorectal cancer cells. Oncol Rep. 33:1579–1584. 2015.PubMed/NCBI
20	Kim YT and Leech RH: Effects of climatic conditions on sap flow in sugar maple. For Chron. 61:303–307. 1985. View Article : Google Scholar
21	Marvin JW and Erickson RO: A statistical evaluation of some of the factors responsible for the flow of sap from the sugar maple. Plant Physiol. 31:57–61. 1956. View Article : Google Scholar : PubMed/NCBI
22	Plamondon AP and Bernier PY: Modélisation de la coulée de l'érable à sucre (Acersaccharum Marsh.) à partir d'éléments météorologiques. Can J Res. 10:152–157. 1980. View Article : Google Scholar
23	Houle D, Paquette A, Côté B, Logan T, Power H, Charron I and Duchesne L: Impacts of Climate Change on the Timing of the Production Season of Maple Syrup in Eastern Canada. PLoS One. 10:e01448442015. View Article : Google Scholar : PubMed/NCBI
24	Stuckel JG and Low NH: The chemical composition of 80 pure maple syrup samples produced in North America. Food Res Int. 29:373–379. 1996. View Article : Google Scholar
25	Huang JS, Yao CJ, Chuang SE, Yeh CT, Lee LM, Chen RM, Chao WJ, Whang-Peng J and Lai GM: Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 16:2452016. View Article : Google Scholar : PubMed/NCBI
26	Jiang Y, Zhang Q, Bao J, Du CH, Wang J, Tong Q and Liu C: Schisandrin B suppresses glioma cell metastasis mediated by inhibition of mTOR/MMP-9 signal pathway. Biomed Pharmacother. 74:77–82. 2015. View Article : Google Scholar : PubMed/NCBI
27	Hyun S, Kim MS, Song YS, Bak Y, Ham SY, Lee DH, Hong J and Yoon DY: Peroxisome proliferator-activated receptor-gamma agonist 4-O-methylhonokiol induces apoptosis by triggering the intrinsic apoptosis pathway and inhibiting the PI3K/Akt survival pathway in SiHa human cervical cancer cells. J Microbiol Biotechnol. 25:334–342. 2015. View Article : Google Scholar : PubMed/NCBI
28	Zilla MK, Nayak D, Amin H, Nalli Y, Rah B, Chakraborty S, Kitchlu S, Goswami A and Ali A: 4′-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells. Chem Biol Interact. 224:100–107. 2014. View Article : Google Scholar : PubMed/NCBI
29	Jeon YJ, Cho JH, Lee SY, Choi YH, Park H, Jung S, Shim JH and Chae JI: Esculetin Induces Apoptosis Through EGFR/PI3K/Akt Signaling Pathway and Nucleophosmin Relocalization. J Cell Biochem. 117:1210–1221. 2016. View Article : Google Scholar : PubMed/NCBI
30	Hsieh CJ, Kuo PL, Hou MF, Hung JY, Chang FR, Hsu YC, Huang YF, Tsai EM and Hsu YL: Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling. Int J Oncol. 46:555–562. 2015.PubMed/NCBI
31	Kim WJ, Lee MY, Kim JH, Suk K and Lee WH: Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation. Cancer Lett. 296:35–42. 2010. View Article : Google Scholar : PubMed/NCBI